1. Saydam, G., F. Sahin, D. Bozkurt, S.B. Omay ve F. Büyükkececi, “Vena cava superior syndrome due to sternal plasmacytoma in the course of systemic myeloma”, Haematologia, 32(4),529–533 (2002).
  2. Saydam, G., D. Bozkurt, F. Sahin, S. Yuksel, M. Hekimgil, S.B. Omay ve F. Buyukkececi, “Acral sclerosis due to Interferon –Alpha 2b in Chronic Myeloid Leukemia”, Acta Haematologica, 107,43–45 (2002).
  3. Saydam, G., H.H. Aydin, F. Sahin, O. Kucukoglu, E. Erciyas, E. Terzioglu, F. Buyukkececi ve S. B. Omay, “Cytotoxic and inhibitory effects of 4,4’-dihydroxy chalcone (RVC–588) on proliferation of human leukemic HL–60 cells” Leuk Res. 27(1),57–64 (2003).
  4. Saydam, G., H.H. Aydin, F. Sahin, N. Selvi, G. Oktem, E. Terzioglu, F. Buyukkececi ve S.B.Omay, “Involvement of protein phosphatase 2A in interferon-alpha-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells”, Leuk Res. 27(8),709–717 (2003).
  5. Ercan, E., I. Tengiz, C. Sekuri, F. Sahin, E. Aliyev, M. Akın ve U. Acıkel, “Cardiac thrombi in a patient with protein C and S deficiencies: a case report”, Thromb J. 28-2(1), 2 (2004).
  6. Tengiz, I., E. Ercan, F. Sahin, E. Alioglu, C. Duman, G. Saydam ve F.  Buyukkececi, “Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma”, Curr Control Trials Cardiovasc Med. 27,6(1),2 (2005).
  7. Gunduz, C., C. Biray, B. Kosova, B. Yilmaz, Z. Eroglu, F. Sahin, S. B. Omay ve O. Cogulu, “Evaluation of Manisa propolis effect on leukemia cell line by telomerase activity”, Leuk Res. 29(11), 1343–1346 (2005).
  8. Sahin, F., G. Saydam, Y. Ertan, C. Cali, A. Donmez ve M. Tombuloglu,  “Dural plasmacytoma mimicking meningioma in a patient with multiple myeloma”, J Clin Neurosci. 13(2), 259–261 (2006).
  9. Sahin, F., UO. Turk, F. Yargucu, A. Donmez ve S. Cagirgan, “Hypothermia during the Infusion of Cryopreserved Autologous Peripheral Stem Cell Causes Electrocardiographical Changes: Report of Two Cases”, Am J Hematol. 81, 627–630 (2006).
  10. Sahin, F., Y. Kucukzeybek, N. Selvi, H. A. Celik, H. H. Aydin, S. B. Omay ve G. Saydam, “Nitric oxide level and expression of iNOS increase in de novo acute myeloid leukaemia blasts and HL 60 cell”, Haema, 9(4), 560-566 (2006).
  11. Sahin, F., I. Y. Simsir, Y. Ertan, A. Sever, F. Buyukkececi ve G. Saydam, “Complete disappearance of bone lesions with high dose chemotherapy supported with autologous stem cell transplantation in primary bone lymphoma”, Haema, 9(4), 572-575 (2006).
  12. Sahin, F., N. A. Soyer, M. Argin, Y. Ertan, G. Saydam, F. Vural ve M. Tombuloglu, “Amyloid deposition in knee and ankle joints in the course of multiple myeloma”, Joint Bone Spine, 74(2), 209-211 (2007).
  13. Sahin, F., G. Saydam, O. Sahin, S. Ocakci, Y. Ertan, U. S. Akarca ve M. Tombuloglu, “Acute lymphoblastic leykemia in apatient with wilson disease treated with D-pencillamine”, Haema, 9(5), 688-690 (2006).
  14. Sahin, F., Z. Sercan, Y. Ertan, S. Ocakci, E. Ay, F. Vural, E. Yuksel, M. Tombuloglu ve G. Saydam, “Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: A case report”, Hematology,12(6), 489-492 (2007).
  15. Avci, C. B. F. Sahin, C. Gunduz, N. Selvi, H. H. Aydin, G. Oktem, N. Topcuoglu ve G. Saydam,  “Protein phosphatase 2A (PP2A) has a potential role in CAPE-induced apoptosis of CCRF-CEM cells via effecting human telomerase reverse transcriptase activity”, Hematology, 12(6), 519- 525 (2007).
  16. Sahin, F., H. A. Celik, H. H. Aydin, G. Oktem, S. B. Omay ve G. Saydam, “The interaction between taxoids and serine/threonine protein phosphatase activities during taxan-induced apoptosis of HL 60 leukemic cells”, Hematology, 13(4), 215-223 (2008).
  17. Saraç, F., G. Saydam, F. Sahin, K. Oztekin, F. Saygili, M. Tüzün ve C. Yilmaz, “Effects of hormone replacement therapy on insulin resistance and platelet function tests”, Med Princ Pract. 18(1), 43-47 (2009).
  18. Alioglu, E., N. Tuzun, F. Sahin, B. Kosova, S. Saygi, I. Tengiz, U. Turk, N. Ozsan ve E. Ercan, “Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia”, Thromb J. 20, 7, 1 (2009).
  19. Gürbüz, Y., F. Şahin, S. Özdedeli, G. Oktem, Ç.B. Avcı, G. Saydam and O. Ozdemir. “Experimental repair of rabbit segmental bone defects by using autologous bone marrow and electrical stimulation”, Türkiye Klinikleri, Tıp Blimleri Dergisi. 30, 2 (2010).
  1. Sahin F., C. B. Avci, C. Gunduz, C. Sezgin, I.Y. Simsir and G. Saydam. “Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity” Hematology 15( 3), 144—150, (2010).
  2. Saydam, G., B. Kosava, F. Şahin. Successful dasatinib treatment in chronic   myeloid leukaemia after long-term imatinib failure: Case report. International J Hemat Oncol.(UHOD). 2(1), 20;17-21, (2010).
  3. Avcı, C.B., C. Gündüz, Y. Baran, F. Sahin, S. Yılmaz, Z.O. Dogan, G. Saydam. “Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells”, J Cancer Res Clin Oncol.137(1):41-7, (2011).
  4. Cakir, Z., G. Saydam, F. Sahin, Y. Baran. “The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells”, J Cancer Res Clin Oncol. 137(2):279-86,(2011).
  5. Kartal, M., G. Saydam, F. Sahin and Y. Baran. Resveratrol Triggers Apoptosis Through Regulating Ceramide Metabolizing Genes in Human K562 Chronic Myeloid Leukemia Cells. Nutr Cancer. 63(4):637-44, (2011).
  6. Soyer, N., A. Ş.Küçükarslan, F. Şahin, D. Çekdemir, B. Kosova, Z. Eroğlu,  M. Töbü, M. Tombuloğlu, S. Çağırgan, A. Dönmez, F. Vural, G. Saydam. Factor V G1691A(Leiden) and prothrombin G20210A gene mutation status, and thrombosis in patients with chronic myeloproliferative disorders. Turk J Hematol, 28, 306-311; (2011).
  7. Saygi S, Alioglu E, Karabulut MN, Turk UO, Kirilmaz B, Tuzun N, Sahin F, Kosova B, Tengiz I. A Floating Thrombus in Sinus of Valsalva Complicated with Cardiogenic Shock in a Patient with Plasminogen Activator Inhibitor 1 4G/5G Polymorphism. Echocardiography. 28(8):E164-7. (2011).
  8. Palamar M, Midilli R, Ozsan N, Egrilmez S, Sahin F, Yagci A. Primary diffuse large B-cell lymphoma of the lacrimal sac simulating chronic dacryocystitis. Auris Nasus Larynx. 38(5):643-5, (2011)
  9. Avci CB, Yilmaz S, Dogan ZO, Saydam G, Dodurga Y, Ekiz HA, Kartal M, Sahin F, Baran Y, Gunduz C. Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells. Hematology. 16(5):303-7, (2011).
  10. Aksu, K., S. Cagirgan, N. Ozsan, G. Keser, F. Sahin. Non-Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis. Rheumatol Int. 31(12):1645-7( 2011).
  11. Turk U, Basol G, Barutcuoglu B, Sahin F, Habif S, Tarugi P, Bayindir O. A 54-year-old diabetic man with low serum cholesterol. Clin Chem. 58(5):826-9, (2012).
  12. Kaymaz BT, Selvi N, Saydam G, Sahin F, Kosova B.Methylprednisolone induces apoptosis by interacting with the JAK/STAT pathway in HL-60 and K-562 leukemic cells. Hematology. 2012 Mar;17(2):93-9.
  13. Purclutepe O, Iskender G, Kiper HD, Tezcanli B, Selvi N, Avci CB, Kosova B, Gokbulut AA, Sahin F, Baran Y, Saydam G. Enalapril-induced Apoptosis of Acute Promyelocytic Leukaemia Cells Involves STAT5A. Anticancer Res. 2012 Jul;32(7):2885-93.
  14. S. Aksu, F. Sahin, B.Uz, A.S.Yavuz, H. Atay, E. Kelkitli, M.Turgut, M. Pehlivan, M.O. Akay, E.Gürkan, M. Demir, S. Kahraman, F. Demirkan, S. Paydaş, G. Saydam, İ.C.Haznedaroğlu. The Clinical impact of low doses of dasatinib in patients with chronic myeloid leukemia. Int J Hemat Oncol (UHOD), 1(22),8-14, 2012.
  15. F. Vural, G. Saydam, F. Sahin, N.A. Soyer, M. Hekimgil, S. Ocakçı, M. Tombuloğlu, S. Cagirgan. Non-Hodgkin’s Lymphoma of the Breast: Report of five cases and review of the literature. Int J Hemat Oncol (UHOD), 3(22),195-201, 2012.
  16. Kaymaz BT, Selvi N, Gokbulut AA, Aktan Ç, Gündüz C, Saydam G, Şahin F, Çetintaş VB, Baran Y, Kosova B. Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosis. Am J Blood Res 2013;3(1):58-70.
  17. Kiper HD, Tezcanli Kaymaz B, Gokbulut AA, Selvi N, Avci CB, Kosova B, Iskender G, Yandim MK, Gunduz C, Sahin F, Baran Y, Saydam G. STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells.  Biomed Pharmacother. 2013 Jul;67(6):527-32.
  18. Cömert M, Güneş AE, Sahin F, Saydam G. Quality of Life and Supportive Care in Multiple Myeloma. Review. Turk J Haematol. 2013 Sep;30(3):234-246.
  19. Sahin F, Saydam G, Cömert M, Uz B, Yavuz AS, Turan E, Yönal I, Atay H, Keltikli E, Turgut M, Pehlivan M, Akay MO, Gürkan E, Paydaş S, Kahraman S, Demirkan F, Kırkızlar O, Akpınar S, Pamuk GE, Demir M, Ozbaş HM, Sönmez M, Gültürk M, Salihoğlu A, Eşkazan AE, Ar C, Haydaroğlu Şahin H, Ongören S, Başlar Z, Aydın Y, Yenere MN, Tüzüner N, Ferhanoğlu B, Haznedaroglu IC, Ilhan O, Soysal T. Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients. Turk J Haematol. 2013 Dec;30(4):351-8.
  20. Yilmaz AF, Saydam G, Sahin F, Baran Y. Granulocytic sarcoma: a systematic review. Am J Blood Res. 2013 Dec 18;3(4):265-270.
  21. Selvi N, Kaymaz BT, Gündüz C, Aktan C, Kiper HD, Sahin F, Cömert M, Selvi AF, Kosova B, Saydam G. Bortezomib induces apoptosos by interacting with JAK/STAT pathway in K562 leukemic cells. Tumour Biol. 2014 Aug;35(8):7861-70.
  22. Tasar PT, Sahin S, Yilmaz AF, Dalgic CT, Gokmen ENM, Akcicek F, Saydam G, Sahin F. Perforation of Ileum Due to Thrombosis in the Course of Paroxysmal Nocturnal Hemoglobinuria: A Case Report. International Journal of Case Reports in Medicine, 2014 Apr; 1-4.
  23. Sahin F, Yilmaz AF, Comert M, Ozdemirkiran F, Gokmen NM, Saydam G. Spontaneous Remission of Paroxysmal Nocturnal Hemoglobinuria During Eculizumab Treatment. J Hematol. 2014; 3(2):50-53.
  24. Vural F, Karaca E, Soyer N, Gunduz C, Sahin F, Kosova B, Saydam G, Cagirgan S, Tombuloglu M, Ozkinay F, Cogulu O. Kronik Lenfositik Lösemili Hastalarda Bilinen Prognostik Belirteçlerin CD38 ZAP70 ve hTERT Ekspresyonları ile Beş Yıllık Takip Döneminde Karşılaştırılması. UHOD. 2014, 24,(3): 179-184.
  25. Ayyildiz O, Demirkan F, Goker H, Haznedaroglu IC, İlhan O, Kaynar LG, Ozdemir E, Saydam G, Sayinalp N, Sahin F, Turgut M, Unal A, Vural F. İbrutinib: Molekülden ilaca. UHOD. 2014, 24(3): 4-14.
  26. Cetinkalp S, Simsir IY, Sahin F, Saydam G, Ural AU, Yilmaz C. Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment?  Saudi Pharm J. 2015 Jan;23(1):14-21.                                                                       
  27. Ozkan MC, Sahin F, Saydam G. Immune Trombocytopenic Purpura: New Biological Therapy of an Old Disease. Curr Med Chem. 2015;22(16):1956-62.
  28. Özdemirkıran F, Payzın B, Kiper HD, Kabukçu S, Akgün Çağlıyan G, Kahraman S, Sevindik ÖG, Ceylan C, Kadıköylü G, Şahin F, Keskin A, Arslan Ö, Özcan MA, Görgün G, Bolaman Z, Büyükkeçeci F, Bilgir O, Alacacıoğlu İ, Vural F, Tombuloğlu M, Gökgöz Z, Saydam G.Eltrombopag for the Treatment of Immune Thrombocytopenia: The Aegean Region of Turkey Experience. Turk J Haematol. 2015, Dec;32(4):323-8.
  29. Ozkan MC, Sahin F, Saydam G. Peripheral blood stem cell mobilization from healthy donors. Transfus Apher Sci. 2015 Aug;53(1):13-6.
  30. Sahin F, Ozkan MC, Mete NG, Yilmaz M, Oruc N, Gurgun A, Kayikcioglu M, Guler A, Gokcay F, Bilgir F, Ceylan C, Bilgir O, Sari IH, Saydam G. Multidisciplinary clinical management of paroxysmal nocturnal hemoglobinuria. Am J Blood Res. 2015 Jun 15;5(1):1-9. eCollection 2015. Review.
  31. Sahin F, Yilmaz AF, Ozkan MC, Gokmen NM, Saydam G. PNH is a debilitating, fatal but treatable disease: same disease, different clinical presentations. Am J Blood Res. 2015 Jun 15;5(1):30-3. eCollection 2015.
  32. Özkan MC, Palamar M, Tombuloğlu M, Hekimgil M, Özsan N, Saydam G, Şahin F. Ocular Adnexal Lymphomas: Single-Center Experience. Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S158-60.
  33. Dalgıç CT, Kaymaz BT, Özkan MC, Dalmızrak A, Şahin F, Saydam G. Investigating the Role of JAK/STAT Pathway on Dasatinib-Induced Apoptosis for CML Cell Model K562. Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S161-6.
  34. Patir P, Isik Y, Turk Y, Ugur MC, Ceylan C, Gorgun G, Mete Gokmen N, Saydam G, Sahin F. Necrotizing fasciitis in Paroxysmal nocturnal hemoglobinuria. Case Rep Hematol. 2015;2015:908087. doi: 10.1155/2015/908087.
  35. Melda Comert Ozkan, Murat Tombuloglu, Fahri Sahin, Guray Saydam. Evaluation of immunomodulatory drugs in multiple myeloma: single center experience. Am J Blood Res 2015;5(2):95-100.
  36. Keklik F, Özkan MC, Yenipazar GK, Yaman B, Saydam G, Sahin F.Toxic epidermal necrolysis associated with radiotherapy and phenytoin in a patient with non-Hodking's lymphoma: A case report. Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):81-3.
  37. Sahin S, Tasar PT, Simsek H, Çicek Z, Eskiizmirli H, Aykar FS, Sahin F, Akcicek F. Prevalence of anemia and malnutrition and their association in elderly nursing home residents. Aging Clin Exp Res. (2016) 28:857-862.
  38. Aksu S, Ayyildiz O, Etgul S, Goker H, Gunes G, Haznedaroglu IC, Ilhan O, Kaynar LG, Malkan UY, Ozdemir E, Saydam G, Sayinalp N, Sahin F, Turgut M, Unal A. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders. UHOD 2016 1, Suppl 1 (26): 12-19.
  39. Soyer N, Haznedaroğlu İC, Cömert M, Çekdemir D, Yılmaz M, Ünal A, Çağlıyan G, Bilgir O, İlhan O, Özdemirkıran F, Kaya E, Şahin F, Vural F, Saydam G. Multicenter-Retrospective Analysis Of Turkish Patients With Chronic Myeloproliferative Neoplasms. Turk J Haematol. 2016 Apr 18. doi: 10.4274/tjh.2016.0005. [Epub ahead of print]
  40. Sahin F, Akay OM, Ayer M, Dal MS, Ertop S, Ilhan O, Karakus V, Ozcan MA, Ozkocaman V, Ozsan H, Salim O, Tobu M, Tombak A, Tuglular TF, Yilmaz M, Unal A, Yenerel MN, Saydam G. Pesg PNH diagnosis, follow-up and treatment guidelines. Am J Blood Res.  5;6(2):19-27. 2016.
  41. Palamar M, Ozsan N, Sahin F. Bilateral lacrimal gland lymphoma in Sjögren Sendrome. Case Rep Ophthalmol Med.1-3. 2016.
  42. Nur Soyer, Ferit Celik, Murat Tombuloglu, Fahri Sahin, Guray Saydam, Filiz Vural. Role of Allogeneic Stem Cell Transplant in the Treatment of Primary Myelofibrosis. Exp Clin Transplant. 2016 Nov 18. doi: 10.6002/ect.2016.0007. [Epub ahead of print]. 2016.
  43. Anıl Tombak, M.Ali Uçar, Aydan Akdeniz, E.Naci Tiftik, D.Gören Şahin, O.Meltem Akay, Murat Yıldırım, Oral Nevruz, Cem Kis, Emel Gürkan, Ş.Medeni Solmaz, M. Ali Özcan, Rahşan Yıldırım, İlhami Berber, M.Ali Erkut, T. Fıratlı Tuğlular, Pınar Tarkun, İrfan Yavaşoğlu, M.Hilmi Doğu, İsmail Sarı, Mustafa Merter, Muhit Özcan, Esra Yıldızhan, Leylagül Kaynar, Özgür Mehtap, Ayşe Uysal, Fahri Şahin, Ozan Salim, M.Ali Sungur. The role of Azacitidine in the treatment of elderly patients with acute myeloid leukemia: Results of a retrospective multicenter study. Turk J Hematol. 2016; 33:273-280.
  44. Gediz F, Payzin BK, Cakmak OZ, Uzum Y, Ernur D, Sahin F. Paroxysmal nokturnal hemoglobinuria in the differebtial diagnosis of thrombocytopenia. Hematol Rep. 2017, 22;9(1):6682.
  45. Yilmaz AF, Soyer N, Ozsan N, Cagirgan S, Gunes A, Comert M, Sahin F, Saydam G, Gunel NS, Vural F. Extramedullary Relapse in a CML Patient after Allogeneic Stem Cell Transplantation. Case Rep Hematol. 2017, 6350267. doi: 10.1155/2017/6350267.
  46. Soyer N, Yilmaz AF, Özsan N, Şahin F, Saydam G, Tombuloğlu M, Hekimgil M, Vural F. Retrospective analysis of primary gastric diffuse largeB-cell lymphoma: a single center study from Turkey. Turk J Med Sci. 2017 Feb 27;47(1):240-245.
  47. Soyer N, Tezcanlı Kaymaz B, Cömert Özkan M, Aktan Ç, Küçükaslan AŞ, Şahin F, Kosova B, Saydam G. TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms. Turk J Haematol. 2017 Jun 5;34(2):174-178.
  48. Arslan F, Alp S, Büyükasık Y, Ozkan MC, Şahin F, Basaran S, Cagatay AA, Eraksoy ÖH, Aksu K, Ertunç B, Korten V, Ceylan B, Mert A. Hemophagocytic Lymphohistiocytosis in Adults: Low Incidence of Primary Neoplasm as a Trigger in a Case Series from Turkey. Mediterr J Hematol Infect Dis. 2018 Sep 1;10(1):e2018047. doi: 10.4084/MJHID.2018.047. eCollection 2018. (SCI-E)
  49. Patir P, Soyer N, Durusoy IR, Sahin F, Saydam G, Tobu M, Tombuloglu M, Vural F. A Retrospective Comparison of TECAM and BEAM Conditioning Regimens Before Autologous Hematopoietic Stem Cell Transplant in Lymphoma Patients: Efficacy and Toxicity. Exp Clin Transplant. 2018 Jun 28. doi: 10.6002/ect.2017.0274. (SCI-E)
  50. Karakus V, Dere Y, Dere O, Sahin F, Ozsan N. Gaucher disease in an adult: A rare cause of hepatosplenomegaly in adults. North Clin Istanb. 2018 Jan 9;5(1):58-59. doi: 10.14744/nci.2017.01336. eCollection 2018.  (ESCI)
  51. Soyer N, Patır P, Uysal A, Duran M, Ünal HD, Durusoy R, Tombuloğlu M, Şahin F, Töbü M, Vural F, Saydam G. Efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/ refractory multiple myeloma: a real-life experience. Turk J Med Sci. 2018 Aug 16;48(4):777-785. doi: 10.3906/sag-1712-160. (SCI-E)
  52. Uysal A, Akad Soyer N, Özkan M, Şahin F, Vural F, Töbü M, Tombuloğlu M, Saydam G. Carfilzomib experience in relapsed/refractory multiple myeloma: a single-center experience. Turk J Med Sci. 2018 Feb 23;48(1):80-83. doi: 10.3906/sag-1611-97. (SCI-EI).
  53. Gemici A1, Aydogdu I2, Terzi H3, Sencan M3, Aslan A4, Kaya AH5, Dal MS5, Akay MO6, Dogu MH7, Ayyildiz O8, Sahin F9, Cagliyan GA10, Yilmaz M11, Gokgoz Z12, Bilen Y13, Demir C14, Sevindik OG15, Korkmaz S16, Eser B17, Altuntas F5; ThREG, Turkish hematology Research and Education Group. Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience. Hematol Oncol. 2018 Feb;36(1):116-120. doi: 10.1002/hon.2460.
  54. İlhan Osman, Narlı Özdemir Zehra, Özet Gülsüm, Falay Mesude, Yenerel Mustafa Nuri, Tuğlular Ayşe Tülin, Turgut Mehmet, Ünal Ali, Ayyıldız Mehmet Orhan, Andıç Neslihan, Hacıhanefioğlu Abdullah, Şahin Fahri, Şencan Mehmet, Ali Rıdvan, Özsan Güner Hayri, Yıldırım Rahşan, Tiftik Eyüp Naci, Tombak Anıl, Salim Ozan, Kaya Emin, Akay Olga Meltem, Okan Vahap, Pehlivan Mustafa, Saydam Güray (2019).  Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patients.  Transfusion and Apheresis Science, 58(5), 659-662., Doi: 10.1016/j.transci.2019.08.021 (Yayın No: 5632227).
  55. Yılmaz Asu Fergün, Atilla Fatoş Dilan, Akkaş Nagehan, Bülbül Hale, Soyer Nur, Demir Derya, Kiper Ünal Hatice Demet, Avcı Aaa, Vural Filiz, Saydam Güray, Şahin Fahri, Hekimgil Mine, Özsan Nazan, Durusoy Onmuş İsabel Raika, Payzın Kadriye Bahriye (2019).  Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years.  Indian Journal of Hematology and Blood Transfusion, 35(4), 692-698., Doi: 10.1007/s12288-019-01132-7 (Yayın No: 5673258).
  56. Dalmızrak Ayşegül, Selvi Günel Nur, Kaymaz Burçin, Şahin Fahri, Saydam Güray, Kosova Buket (2019).  Effects of RİTUXİMAB on JAK-STAT and NF-κB signaling pathways in acute lymphoblastic leukemia and chronic lymphocytic leukemia.  Turkish Journal of Biochemistry, 1(1), 1-11., Doi: 10.1515/tjb-2018-0321 (Yayın No: 5048513).
  57. Soyer N.  , Çelik F.  , Tombuloğlu M.  , Şahin F.  , Saydam G.  , Vural F.  Role Of Allogeneic Stem Cell Transplant in the Treatment of Primary Myelofibrosis. Experımental And Clınıcal Transplantatıon, Cilt.17, Ss.93-96, 2019.
  58. Yılmaz Merve, Atilla Fatoş Dilan, Şahin Fahri, Saydam Güray (2019).  The effect of malnutrition on mortality in hospitalized patients with hematologic malignancy.  Supportive Care in Cancer, Support Care Cancer. 2020 Mar;28(3):1441-1448.
  59. Atik T, Işık E, Onay H, Akgün B, Shamsali M, Kavaklı K, Evim M, Tuysuz G, Ozbek NY, Şahin F, Salcıoğlu Z, Albayrak C, Oymak Y, Unal E, Belen FB, Yılmaz E, Balkan C, Baytan B, Küpesiz A, Culha V, Tahtakesen Gucer TN, Güneş AM, Özkınay F.Factor 8 Gene Mutation Spectrum of 270 Patients With Haemophilia A: Identification of 36 Novel Mutations. Turk J Haematol 2020 Feb 6. doi: 10.4274/tjh.galenos.2020.2019.0262. 
  60. Ozkan Melda Comert, Kaymaz Burçin, Gunes Ajda,Kosova Buket, Soyer Nur,Yılmaz Asu Fergün, Vural Filiz, Şahin Fahri, Saydam Güray.  Investigating the cytotoxic and apoptotic effects of sunitinib upon K-562 chronic myelogenous leukemia cell line and assessment of gene profiling.  J Cancer Res Ther. 2020 Jan-Mar;16(1):150-156.
  61. Gülay Alp, Duygu Aygüneş Jafari, Burçin Kaymaz, Buket Kosova, Fahri Şahin, Güray Saydam. Analysis 0f TET-2, ASXL1, IDH1, IDH2 Gene Polymorphisms and The Correlation with Clinical Parameters in Patients With Myelodysplastic Syndrome. Int J Acad Med Pharm, 2020; 1(2); 40-49.
  62. Miray Yaman, Duygu Aygüneş Jafari, Burçin Kaymaz, Çağdaş Aktan, Buket Kosova, Fahri Şahin, Güray Saydam. Determining Clinical Correleation of Calr Type 1 and Calr Type 2 Gene Mutations in Chronic Myeloproliferative Disease Cases. Int J Acad Med Pharm, 2020; 2(2); 84-89.
  63. Zehra N Ozdemir, Osman Ilhan, Gulsum Ozet, Mesude Falay, Mustafa Yenerel, Tulin Tuglular, Mehmet Turgut, Birol Guvenc, Ali Unal, Orhan Ayyildiz, Neslihan Andic, Abdullah Hacihanefioglu, Fahri Sahin, Mehmet Sencan, Ridvan Ali, Guner H Ozsan, Rahsan Yildirim, Eyup N Tiftik, Anil Tombak, Ozan Salim, Emin Kaya, Olga M Akay, Vahap Okan, Mustafa Pehlivan, Guray Saydam. Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia. Clin Lab. 2020 Sep 1;66(9). doi: 10.7754/Clin.Lab.2020.191218.
  64. Keklik Karadağ Fatma, Saydam Güray, Şahin Fahri (2020).  Is Allogeneic Stem Cell Transplantation a Good Option for Paroxysmal Nocturnal Haemoglobinuria?.  EMJ Hematology (Yayın No: 6628984), Nov, 2020. DOI/10.33590/emjhematol/20-00023. 
  65. Davulcu EA, Demirci Z, Fırat Ö, Saydam G, Şahin F.  Sleeve Gastrectomy in a Severe Hemophilia A Patient: One of the Very Rare Cases. Turk J Haematol. 2020 Nov 19;37(4):304-306. doi: 10.4274/tjh.galenos.2020.2020.0168. Epub 2020 Aug 4.
  66. Aykar Sercan, Can Filiz, Şahin Fahri. Relationship between fear of movement and physicalactivity levels in adult hemophilic individuals. Annals of Medical Research. Ann Med Res 2020;27(1):219-223.
  67. Kartal Yandım Melis, Kozanoğlu İlknur, Ozdoğu Hakan, Pişkin Özden, Özcan Mehmet Ali, Saydam Güray, Şahin Fahri, Avcu Ferit, Ural Ali Uğur, Ünal Ali, Baran Yusuf. Novel biomarkers for tyrosine kinase inhibitor resistance in chronic myeloid leukemia patients: Bioactive sphingolipids. Journal of Hematology and Therapeutics. Jan 2020, 2(1) 1-7.
  68. Baysal E, Sari D, Vural F, Çağırgan S, Saydam G, Töbü M, Şahin F, Soyer N, Gediz F, Acarlar C, Timur E, Güngör A. pH Value in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation. Semin Oncol Nurs. 2021 May 15:151146. doi: 10.1016/j.soncn.2021.151146. Online ahead of print.
  69. Yılmaz F, Soyer N, Cengiz Seval G, Civriz Bozdağ S, Topcuoglu P, Unal A, Kaynar L, Ozgur G, Sucak G, Goker H, Velet M, Ozdogu H, Yılmaz M, Kaya E, Salim O, Deveci B, Karadoğan İ, Saydam G, Sahin F, Vural F. Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or Without Aplastic Anemia: Multicenter Turkish Experience. Turk J Haematol. 2021 May 31. doi: 10.4274/tjh.galenos.2021.2021.0105. Online ahead of print.
  70. Impact of the HEAD-US Scoring System for Observing the Protective Effect of Prophylaxis in Hemophilia Patients: A Prospective, Multicenter, Observational Study. Kavaklı K, Özbek SS, Antmen AB, Şahin F, Aytaç ŞS, Küpesiz A, Zülfikar B, Sönmez M, Çalışkan Ü, Balkan C, Akbaş T, Arpacı T, Tamsel İ, Seber T, Oğuz B, Çevikol C, Bulakçı M, Koşucu P, Aydoğdu D, Şaşmaz İ, Tüysüz G, Koç B, Tokgöz H, Mehrekula Z, Özkan B. Turk J Haematol. 2021 Jun 1;38(2):101-110. doi: 10.4274/tjh.galenos.2021.2020.0717. Epub 2021 Jan 29.
  71. Nur Soyer, Ridvan Ali, Mehmet Turgut, İbrahim Celalettin Haznedaroğlu, Asu Fergün Yilmaz, İsmet Aydoğdu, Ali Pir, Volkan Karakuş, Gökhan Özgür, Cem Kis, Funda Ceran, Gül İlhan, Melda Özkan, MÜzeyyen Aslaner, İdrİs İnce, İrfan Yavaşoğlu, Füsun Gedİz, Mehmet Sönmez, Birol Güvenç, Gülsüm Özet, Emin Kaya, Filiz Vural, Fahri Şahin, Mahmut Töbü, İsabel Raika Durusoy Onmuş, Güray Saydam. Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey Turk J Med Sci. 2021 Jun 28;51(3):1033-1042. doi: 10.3906/sag-1812-70.
  72. Fatma Keklik Karadag, Mustafa Nuri Yenerel, Mehmet Yılmaz, Hava Uskudar, Vildan Ozkocaman, Tülin Firatli Tuglular, Fuat Erdem, Ali Unal, Orhan Ayyildiz, Gülsüm Ozet, Melda Comert, Emin Kaya, Mesut Ayer, Ozan Salim, Birol Guvenc, Hakan Ozdogu, Özgur Mehtap, Mehmet Sonmez, Nil Guler, Sibel Hacioglu, İsmet Aydogdu, Ozlen Bektas, Selami Kocak Toprak, Lale Kaynar, Munci Yagci, Salih Aksu, Anil Tombak, Volkan Karakus, İrfan Yavasoglu, Birgul Onec, Mehmet Ali Ozcan, Levent Undar, Rıdvan Ali, Osman Ilhan, Guray Saydam, Fahri Sahin. Evolution of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in turkey: a multicenter retrospective analysis. Am J Blood Res 2021;11(3):279-285. 
  73. Akdeniz Aydan, Ünüvar Ayşegül, Ar Muhlis Cem, Pekpak Şahinoğlu Esra, Akyay Arzu, Mehtap Özgür, Keklik Karadağ Fatma, Acıpayam Can, Doğan Ali, Ekinci Ömer, Aydın Köker Sultan, Albayrak Canan, Demirci Ufuk, Güney Tekin, Kurt Yüksel Meltem, Karaman Serap, Şahin Kimyon Özge, Albayrak Sinan, Öncül Yurday, Ünal Serkan, Şahin Fahri, Tuna Deveci Rumeysa, Zülfikar Osman Bülent, Belen Apak Fatma Burcu, Ümit Elif Gülsüm, Demir Ahmet Muzaffer (2021). Results of multicenter registry for patients with inherited factor VII deficiency in Turkey. Scandinavian Journal of Clinical and Laboratory Investigation, Doi: 10.1080/00365513.2021.2013524 (Yayın No: 7320319).
  74. Karakus V., Kaya, E., Dere Y., Sahin F. Different clinical courses with the same findings: two cases of paroxysmal nokturnal hemoglobinuria presenting with thrombocytopenia, Italian J of Medicine, 15 (3), 188-190, 2021.
  75. Esma Evrim Dogan, Fatma Keklik Karadag, Demet Aydin, Naciye Demirel, Eren Arslan Davulcu, Esra Turan Erkek, Rafet Eren, Nur Akad Soyer, Fahri Sahin, Güray Saydam. The Effect of Serum Lactate Dehydrogenase (LDH) Level on the Response to Erythropoiesis Stimulating Agents in Patients with Low and Intermediate Risk Myelodysplastic Syndrome.  J Haematol Stem Cell Res. 2021; 1(2): 89-97  (OPEN ACCESS)
  76. Ipek Tamsel, Kaan Kavakli, S. Sureyya Ozbek, Ilhan Hekimsoy, Can Balkan, Fahri Sahin, Sadık Tamsel. The value of ultrasonography in detecting early arthropathic changes and contribution to the clinical approach in patients of hemophilia. J Clin Ultrasound. 2022;50:428–432. doi: 10.1002/jcu.23164 (SCI-E)(Q4)
  77. Kaan Kavaklı, Bülent Antmen, Vahap Okan, Fahri Şahin, Selin Aytaç, Can Balkan, Ergül Berber, Zühre Kaya, Alphan Küpesiz and Bülent Zülfikar. Gene therapy in haemophilia: literature review and regional perspectives for Turkey. Ther Adv Hematol 2022, Vol. 13: 1–17. https://doi.org/10.1177/20406207221104591 . (SCI-E)(Q2)
  78. Mustafa N. Yenerel, Flore Sicre de Fontbrune, Caroline Piatek, Fahri Sahin, Wolfgang Fureder, Stephan Ortiz, Masayo Ogawa, Ayca Ozol-Godfrey, J. Rafael Sierra, Jeff Szer. Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up. Adv Ther. 2022 Oct 22:1-22. doi: 10.1007/s12325-022-02339-3. (SCI-E)(Q3)
  79. Cagla Kayabasi, Ayse Caner, Sunde Yilmaz Susluer, Tugce Balci Okcanoglu, Besra Ozmen Yelken, Aycan Asik, Zeynep Mutlu, Cansu Caliskan Kurt, Bakiye Goker Bagca, Cigir Biray Avci, Fahri Sahin, Guray Saydam, Cumhur Gunduz. Comparative expression analysis of dasatinib and ponatinib‑regulated lncRNAs in chronic myeloid leukemia and their network analysis. Medical Oncology (2022) 39:29 https://doi.org/10.1007/s12032-021-01629-0. (SCI-E)(Q3)
  80. Aydan Akdeniz, Aysegul Unuvar, Muhlis Cem Ar, Esra Pekpak, Arzu Akyay, Ozgur Mehtap, Fatma Keklik Karadag, Can Acıpayam, Ali Dogan, Omer Ekinci, Sultan Aydın Koker, Canan Albayrak, Ufuk Demirci, Tekin Guney, Meltem Kurt, Serap Karaman, Ozge Sahin Kimyon, Sinan Albayrak, Yurday Oncul, Serkan Unal, Fahri Sahin, Rumeysa Tuna, Bulent Zulfikar, Burcu Belen Apak, Elif Gulsum Umitm and Ahmet Muzaffer Demir. Results of multicenter registry for patients with inherited factor VII deficiency in Turkey. Scandınavıan Journal Of Clınıcal And Laboratory Investigation 2022, Vol. 82, No. 1, 28-36. https://Doi.Org/10.1080/00365513.2021.2013524 (SCI-E)(Q4)
  81. Eren Arslan Davulcu, Zühal Demirci, Umut Yılmaz, Muhlis Cem Ar, Hava Üsküdar Teke, Volkan Karakuş, Rafiye Çiftçiler, Cem Selim, İrfan Yavaşoğlu, Salih Sertaç Durusoy, Vahap Okan, Aydan Akdeniz, Alkım Yolcu, İsmet Aydoğdu, Tekin Güney, Asu Fergün Yılmaz, Fahri Şahin. Acquired Hemophilia A In Adults: A Multicenter Study from Turkey. Indian J Hematol Blood Transfus https://doi.org/10.1007/s12288-022-01556-8 (SCI-E) (Q4)
  82. Guray Saydam, Ali Unal, Ibrahim Celalettin Haznedaroglu, Abdullah Hacihanifioglu, Ozgur Mehtap, Erdal Kurtoglu, Mesut Gocer, Mehmet Turgut, Engin Kelkitli, Memis Hilmi Atay, Nil Guler, Basak Unver Koluman, Mehmet Sonmez, Nergiz Erkut, Emin Kaya, Irfan Kuku, Mehmet Ali Erkurt, Gulsum Ozet, Funda Ceran, Fahri Sahin, Nur Soyer, Meliha Nalcaci, Mehmet Yilmaz, Sirac Bozkurt, Birkan Aver, Begum Ozdengulsun, Egemen Ozbilgili & Osman Ilhan. Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia. Future Medicine Ltd, International Journal of Hematologic Oncology, Volume 11, Issue 3, June 2022. https://doi.org/10.2217/ijh-2021-0008
  83. Hasan Cagri Yildirim, Fatos Dilan Atilla, Fahri Sahin, Guray Saydam, Filiz Vural, Murat Tombuloglu, Mahmut Tobu. Detailed Analysis of Follicular Lymphoma over 25 Years: A Single-Center, Retrospective Study. EJMA 2022;2(1):7–12. DOI: 10.14744/ejma.2022.35220.
  84. Zuhal Mehrekula Demirci, Nilufer Demiral Yilmaz, Hale Bulbul, Fatma Keklik Karadag, Fatos Dilan Atilla, Guray Saydam, Fahri Sahin. Adherence to hemophilia patients with prophylaxis: Veritas-Pro and psychometric properties adapted to Turkish.PLOS ONE,1-10 https://doi.org/10.1371/journal.pone.0288625 August 9, 2023.
  85.  Eren Arslan Davulcu, Nur Soyer, Zühal Demirci, Ajda Güneş, Filiz Vural, Fahri Şahin, Mahmut Töbü, Serra Kamer, Mine Hekimgil, Güray Saydam. Adult Onset Langerhans Cell Histiocytosis: Clinical Characteristics and Treatment Outcomes. Clinical Hematology International (2023) 5:101–106 https://doi.org/10.1007/s44228-023-00034-w.
  86. Ahmet Muzaffer Demir, Muhlis Cem Ar, Fahri Şahin, Merve Altunbaş. Level of Awareness of Acquired Hemophilia A Among Physicians in Türkiye: A Survey Study. Turk J Hematol 2023;40:197-201. DOI: 10.4274/tjh.galenos.2023.2023.0236
  87. Mustafa N. Yenerel, Flore Sicre de Fontbrune, Caroline Piatek, Fahri Sahin, Wolfgang Füreder, Stephan Ortiz, Masayo Ogawa, Ayca Ozol-Godfrey, J. Rafael Sierra, Jeff Szer. Phase 3 Study of Subcutaneous Versus Intravenous Ravulizumab in Eculizumab-Experienced Adult Patients with PNH: Primary Analysis and 1-Year Follow-Up. Adv Ther (2023) 40:211–232 https://doi.org/10.1007/s12325-022-02339-3.
  88. Arslan Davulcu E, Demirci Z, Yılmaz U, Ar MC, Teke HÜ, Karakuş V, Çiftçiler R, Selim C, Yavaşoğlu İ, Durusoy SS, Okan V, Akdeniz A, Yolcu A, Aydoğdu İ, Güney T, Yılmaz AF, Şahin F. Acquired Hemophilia A In Adults: A Multicenter Study from Turkey. Indian J Hematol Blood Transfus. 2023 Jan;39(1):107-115. doi: 10.1007/s12288-022-01556-8.
  89. Barış Gezici, Nur Akad Soyer, Ajda Ersoy Güneş, Güray Saydam, Mahmut Töbü, Fahri Şahin, Filiz Vural.Evaluati on of the Effects of Cytomegalovirus and BK Polyomavirus Infections on Overall Survival Following  Allogeneic Stem Cell Transplantation: A Single Center Experience. Clinical Lymphoma Myeloma and Leukemia 23, S523-524.
  90. Barış Gezici, Ajda Ersoy Güneş, Nur Akad Soyer, Güray Saydam, Mahmut Töbü, Fahri Şahin, Filiz Vural. Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience.. Clinical Lymphoma Myeloma and Leukemia 23, S517-518